NDC codes

FDA NDC Directory
Product NDC (as listed)71205-690Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71205-0690Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71205-690-30712050690307120506903030 TABLET in 1 BOTTLE (71205-690-30)Marketed from Aug 26, 2022
71205-690-60712050690607120506906060 TABLET in 1 BOTTLE (71205-690-60)Marketed from Aug 26, 2022
71205-690-90712050690907120506909090 TABLET in 1 BOTTLE (71205-690-90)Marketed from Aug 26, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Doxazosin
Generic name (nonproprietary)
doxazosin
Active ingredients
Doxazosin mesylate — 4 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Proficient Rx LPNDC labeler code 71205
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 202824
Marketing start
Listing expires
Other FDA classes
Adrenergic alpha-Antagonists (Mechanism)
Identifiers
Product ID 71205-690_8de7d5ee-7f9d-447a-af76-7a7fbf3eb33dSPL ID 8de7d5ee-7f9d-447a-af76-7a7fbf3eb33dSPL set ID 8de7d5ee-7f9d-447a-af76-7a7fbf3eb33dRxCUI 197627UNII 86P6PQK0MUUPC 0371205690304
Pharmacologic class
alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205069030 followed by a unit qualifier and the quantity

Package 71205-0690-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Doxazosin tablets, USP are alpha 1 adrenergic antagonist indicated for: • Signs and symptoms of Benign Prostatic Hyperplasia (BPH) • Treatment of Hypertension 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablets, USP are indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood p…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71205-690

What is NDC 71205-690?
71205-690 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Doxazosin.
What is the active ingredient?
Doxazosin mesylate.
Who is the labeler?
Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin?
106 other product NDCs are listed under this name. See all Doxazosin NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
DoxazosinDoxazosin mesylate 2 mg/1TabletOralRising Pharma Holdings, Inc.16571-16616571-0166-01
DoxazosinDoxazosin mesylate 1 mg/1TabletOralRising Pharma Holdings, Inc.16571-16516571-0165-01
DoxazosinDoxazosin mesylate 4 mg/1TabletOralRising Pharma Holdings, Inc.16571-16716571-0167-01
DoxazosinDoxazosin mesylate 8 mg/1TabletOralRising Pharma Holdings, Inc.16571-16816571-0168-01
Doxazosindoxazosin mesylateDoxazosin mesylate 1 mg/1TabletOralAurobindo Pharma Limited59651-89259651-0892-0159651-0892-99
Doxazosindoxazosin mesylateDoxazosin mesylate 2 mg/1TabletOralAurobindo Pharma Limited59651-89359651-0893-0159651-0893-99
Doxazosindoxazosin mesylateDoxazosin mesylate 4 mg/1TabletOralAurobindo Pharma Limited59651-89459651-0894-0159651-0894-99
Doxazosindoxazosin mesylateDoxazosin mesylate 8 mg/1TabletOralAurobindo Pharma Limited59651-89559651-0895-0159651-0895-99
DoxazosinDoxazosin mesylate 4 mg/1TabletOralREMEDYREPACK INC.70518-403170518-4031-00
DoxazosinDoxazosin mesylate 2 mg/1TabletOralREMEDYREPACK INC.70518-396570518-3965-0070518-3965-01

All 107 Doxazosin NDCs

Other NDCs under ANDA 202824

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202824
ProductStrengthForm · routeLabelerProduct NDC
DoxazosinDoxazosin mesylate 1 mg/1TabletOralAccord Healthcare Inc.16729-211
DoxazosinDoxazosin mesylate 4 mg/1TabletOralAccord Healthcare Inc.16729-213
DoxazosinDoxazosin mesylate 2 mg/1TabletOralAccord Healthcare Inc.16729-414
DoxazosinDoxazosin mesylate 8 mg/1TabletOralAccord Healthcare Inc.16729-415
DoxazosinDoxazosin mesylate 1 mg/1TabletOralA-S Medication Solutions50090-2153
DoxazosinDoxazosin mesylate 4 mg/1TabletOralA-S Medication Solutions50090-2172
DoxazosinDoxazosin mesylate 2 mg/1TabletOralA-S Medication Solutions50090-5773
DoxazosinDoxazosin mesylate 4 mg/1TabletOralNorthwind Health Company, LLC51655-109
DoxazosinDoxazosin mesylate 1 mg/1TabletOralBryant Ranch Prepack63629-7891
DoxazosinDoxazosin mesylate 4 mg/1TabletOralNuCare Pharmaceuticals, Inc.66267-377
DoxazosinDoxazosin mesylate 1 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-4272
DoxazosinDoxazosin mesylate 2 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-4273
DoxazosinDoxazosin mesylate 2 mg/1TabletOralREMEDYREPACK INC.70518-1560
DoxazosinDoxazosin mesylate 2 mg/1TabletOralBryant Ranch Prepack71335-0309
DoxazosinDoxazosin mesylate 4 mg/1TabletOralBryant Ranch Prepack71335-0349
DoxazosinDoxazosin mesylate 2 mg/1TabletOraldirect rx72189-117

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in